AGMB · AgomAb Therapeutics NV · Insider Trading
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
Insider Sentiment Score Cluster buy
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-10-08 | Epstein David R |
Director |
Buy↑
Filing footnotes — Common shares (Direct)
The common shares may be represented by American Depositary Shares, each of which currently represents one common share. |
Common shares
|
5,000 |
| 2026-10-06 | Epstein David R |
Director |
Buy↑
Filing footnotes — Common shares (Direct)
The common shares may be represented by American Depositary Shares, each of which currently represents one common share. |
Common shares
|
5,000 |
| 2026-10-06 | Kemula Pierre Thadee Victor |
Chief Financial Officer |
Buy↑
Filing footnotes — Common shares (Direct)
The common shares may be represented by American Depositary Shares, each of which currently represents one common share. |
Common shares
|
2,000 |
| 2026-10-06 | Kemula Pierre Thadee Victor |
Chief Financial Officer |
Buy↑
Filing footnotes — Common shares (Direct)
The common shares may be represented by American Depositary Shares, each of which currently represents one common share. |
Common shares
|
3,000 |
| 2026-10-06 | Knotnerus Tim Jasper |
Director, Chief Executive Officer |
Buy↑
Filing footnotes — Common shares (Direct)
The common shares may be represented by American Depositary Shares, each of which currently represents one common share. |
Common shares
|
5,000 |
| 2026-10-06 | Kemula Pierre Thadee Victor |
Chief Financial Officer |
Buy↑
Filing footnotes — Common shares (Direct)
The common shares may be represented by American Depositary Shares, each of which currently represents one common share. |
Common shares
|
5,000 |
| 2026-10-05 | Epstein David R |
Director |
Buy↑
Filing footnotes — Common shares (Direct)
The common shares may be represented by American Depositary Shares, each of which currently represents one common share. |
Common shares
|
5,000 |
| 2026-10-05 | Knotnerus Tim Jasper |
Director, Chief Executive Officer |
Buy↑
Filing footnotes — Common shares (Direct)
The common shares may be represented by American Depositary Shares, each of which currently represents one common share. |
Common shares
|
6,000 |
| 2026-09-11 | Garcia Marino |
Director, CEO AND PRESIDENT |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The common shares may be represented by American Depositary Shares, each of which currently represents one common share. The exercise price is reported in U.S. dollars and reflects the conversion from EUR to USD at an exchange rate of $1.1616 per EUR 1.00 as of September 10, 2026. 33% of the shares underlying this option shall vest on September 11, 2027, with the remainder vesting in twenty-four equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. |
Stock Option (Right to Buy)
|
57,482 |
| 2026-09-11 | Patel Naimish |
Chief Medical Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The common shares may be represented by American Depositary Shares, each of which currently represents one common share. The exercise price is reported in U.S. dollars and reflects the conversion from EUR to USD at an exchange rate of $1.1616 per EUR 1.00 as of September 10, 2026. 33% of the shares underlying this option shall vest on September 11, 2027, with the remainder vesting in twenty-four equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. |
Stock Option (Right to Buy)
|
56,328 |